AMR, commonly known as “drug resistance”, occurs when bugs such as bacteria, viruses and fungi become immune to medicines that once killed them or inhibited their growth. Resistance poses a serious threat to universal health coverage and the sustainable development goals, and is significantly accelerated by the increasing use of antimicrobial drugs such as antibiotics. The launch of the Indo-Pacific Centre for Health Security under the Department of Foreign Affairs and Trade (DFAT) has now made AU$300 million available for responding to nearby infectious disease threats, with antimicrobial resistance earmarked as a key concern. Read more
Tackling the global danger of drug-resistance: how far have we come?
The Interpreter published by Lowy Institute